Here, we report the effect of 11β-HSD inhibitor CBX, on obesity and associated co-morbidities in WNIN/Ob obese rat, a novel genetically obese rat model. This evidence concerns the gene CBX1 and obesity due to melanocortin 4 receptor deficiency.